Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farzaneh Darbeheshti

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Advances in Experimental Medicine and Biology|March 14, 2022
The Immunogenetics of MelanomaFarzaneh Darbeheshti
Medical Hypotheses|May 17, 2020
Genetic predisposition models to COVID-19 infectionFarzaneh Darbeheshti, Nima Rezaei
International Journal of Molecular Sciences|January 21, 2023
Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid BiopsiesFarzaneh Darbeheshti, G Mike Makrigiorgos
Immunotherapy|March 29, 2021
Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancerMobina Jalalvand, Farzaneh Darbeheshti, Nima Rezaei
Molecular Biology Reports|May 9, 2022
Prospect of exosomal circular RNAs in breast Cancer: presents and futureElham Zokaei, Farzaneh Darbeheshti, Nima Rezaei
Cancers|July 9, 2022
Pre-PCR Mutation-Enrichment Methods for Liquid Biopsy ApplicationsFarzaneh Darbeheshti, Fangyan Yu, G Mike Makrigiorgos
Cancer Reports (Hoboken, N.J.)|September 5, 2020
Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanismsSepideh Kadkhoda, Farzaneh Darbeheshti, Javad Tavakkoly-Bazzaz
Journal of Cellular Physiology|May 14, 2019
Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactionsFarzaneh Darbeheshti, Nima Rezaei, Mahsa M Amoli, et al.
Clinical Chemistry|June 18, 2022
Recent Developments in Mutation Enrichment and Detection TechnologiesFarzaneh Darbeheshti, Fangyan Yu, Farzana Ahmed, et al.
Journal of the Egyptian National Cancer Institute|April 28, 2024
miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a reviewHosein Kouchaki, Parnia Kamyab, Farzaneh Darbeheshti, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|March 14, 2022
The Immunogenetics of MelanomaFarzaneh Darbeheshti
Medical Hypotheses|May 17, 2020
Genetic predisposition models to COVID-19 infectionFarzaneh Darbeheshti, Nima Rezaei
International Journal of Molecular Sciences|January 21, 2023
Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid BiopsiesFarzaneh Darbeheshti, G Mike Makrigiorgos
Immunotherapy|March 29, 2021
Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancerMobina Jalalvand, Farzaneh Darbeheshti, Nima Rezaei
Molecular Biology Reports|May 9, 2022
Prospect of exosomal circular RNAs in breast Cancer: presents and futureElham Zokaei, Farzaneh Darbeheshti, Nima Rezaei
Cancers|July 9, 2022
Pre-PCR Mutation-Enrichment Methods for Liquid Biopsy ApplicationsFarzaneh Darbeheshti, Fangyan Yu, G Mike Makrigiorgos
Cancer Reports (Hoboken, N.J.)|September 5, 2020
Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanismsSepideh Kadkhoda, Farzaneh Darbeheshti, Javad Tavakkoly-Bazzaz
Journal of Cellular Physiology|May 14, 2019
Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactionsFarzaneh Darbeheshti, Nima Rezaei, Mahsa M Amoli, et al.
Clinical Chemistry|June 18, 2022
Recent Developments in Mutation Enrichment and Detection TechnologiesFarzaneh Darbeheshti, Fangyan Yu, Farzana Ahmed, et al.
Journal of the Egyptian National Cancer Institute|April 28, 2024
miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a reviewHosein Kouchaki, Parnia Kamyab, Farzaneh Darbeheshti, et al.
Pageof 4